|
Q4 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Property, plant and equipment | |||||||||
| Intangible assets and goodwill | |||||||||
| Trade and other receivables | |||||||||
| Investment in equity-accounted investees | |||||||||
| Other investments | |||||||||
| Term deposits | |||||||||
| Non-current tax assets, net | |||||||||
| Deferred tax assets, net | |||||||||
| Other non-current assets | |||||||||
| Total non-current assets | |||||||||
| Inventories | |||||||||
| Contract assets | |||||||||
| Current tax assets, net | |||||||||
| Other current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Total current assets | |||||||||
| Total assets | |||||||||
| Equity | |||||||||
| Share capital | |||||||||
| Share premium | |||||||||
| Other components of equity | |||||||||
| Accumulated deficit | |||||||||
| Total equity attributable to owners of the Company | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| Liabilities | |||||||||
| Loans and borrowings | |||||||||
| Employee benefits | |||||||||
| Contract liabilities and related payables | |||||||||
| Deferred tax liabilities, net | |||||||||
| Other non-current liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Bank overdraft | |||||||||
| Trade and other payables | |||||||||
| Contract liabilities | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| Total equity and liabilities | |||||||||
Loading...
